Abstract:The purpose of the research is to examine the advantages and difficulties of target-site drug delivery methods, with an emphasis on the application of polyethylene glycol (PEG) to enhance drug solubility, bioavailability, and immune response characteristics. It has been demonstrated that this method lowers immunogenicity, enhances pharmacokinetics, and helps drugs pass the blood-brain barrier while reducing reticuloendothelial system clearance. PEG and its derivatives are being used more and more to alter therapeutic substances, offering an escape from some of the drawbacks of conventional medication formulations. In the review, different PEGylation tactics are examined, including cutting-edge methods for reversing multi-drug resistance in nanocarriers. PEGylation has a number of benefits, but there are still drawbacks, including the immunogenic reaction to PEG, which is sometimes referred to as "anti-PEG antibodies," and stability problems that call for the creation of countermeasures. The study devotes a large amount of its space to listing FDA-approved PEGylated medications, emphasizing their therapeutic advantages and clinical uses in a range of medical specialties. The research also explores the regulatory environment that surrounds PEG, closely examining its effectiveness and safety in medication compositions. The review goes beyond PEGylation and includes lipid-based nanocarriers, including liposomes, nanostructured lipid carriers (NLCs), and solid lipid nanoparticles (SLNs). Because these nanocarriers can target specific tissues or cells, improve bioavailability, and encapsulate pharmaceuticals, they are becoming more and more significant in drug delivery systems. The Target Product Profile (TPP) and Quality by Design (QbD) principles serve as the foundation for the creation and characterization of these lipid-based systems. These tools direct the methodical assessment of material properties and risk assessments during the formulation phase. This method guarantees that the finished product satisfies the appropriate requirements for efficacy, safety, and quality. The regulatory status and safety profile of nano lipid carriers are covered in the paper's conclusion, which emphasizes the importance of careful examination and oversight in bringing these cutting-edge products to market. Overall, this thorough analysis highlights the revolutionary potential of lipid-based nanocarriers and PEGylation in improving drug delivery and therapeutic efficacy, but it also draws attention to the continued difficulties and legal issues that need to be resolved in order to fully reap the benefits of these technologies in biomedicine.

Protein-based Emulsion Gels As Materials for Delivery of Bioactive Substances: Formation, Structures, Applications and Challenges

Recent advances in polysaccharides stabilized emulsions for encapsulation and delivery of bioactive food ingredients: A review

Recent Advances in Peptide Engineering of PEG Hydrogels: Strategies, Functional Regulation, and Biomedical Applications

Development of Emulsion Gels for the Delivery of Functional Food Ingredients: from Structure to Functionality

Food Gels Based on Polysaccharide and Protein: Preparation, Formation Mechanisms, and Delivery of Bioactive Substances

Recent Advances in Protein-Based Multilayer Emulsions: Fabrication, Characterization, and Applications: A Review

Effect of polyethylene glycol on polysaccharides: From molecular modification, composite matrixes, synergetic properties to embeddable application in food fields

Polysaccharide-Based Edible Gels as Functional Ingredients: Characterization, Applicability, and Human Health Benefits

Application of Star Poly(ethylene Glycol) Derivatives in Drug Delivery and Controlled Release.

Pickering emulsions stabilized by prolamin-based proteins as innovative carriers of bioactive compounds

Controlled synthesis of PEGylated polyelectrolyte nanogels as efficient protein carriers

Discrete Polyethylene Glycol Derivatives As a Potent Impetus for Next-Generation Biomedicines

Design of gel structures in water and oil phases for improved delivery of bioactive food ingredients

Emulsion gels with different proteins at the interface: Structures and delivery functionality

Research progress on the PEGylation of therapeutic proteins and peptides (TPPs)

Enzymatically Cross-Linked Hydrogels Based on a Linear Poly(ethylene Glycol) Analogue for Controlled Protein Release and 3D Cell Culture

PEO-PPO-PEO As Novel Functional Molecules for Biomedical Material

Tailoring the Properties of Double-Crosslinked Emulsion Gels Using Structural Design Principles: Physical Characteristics, Stability, and Delivery of Lycopene.

Optimized Synthesis of Biodegradable Elastomer PEGylated Poly(glycerol sebacate) and Their Biomedical Application

PEGylation in Pharmaceutical Development: Current Status and Emerging Trends in Macromolecular and Immunotherapeutic Drugs

Engineering Emulsion Gels as Functional Colloids Emphasizing Food Applications: A Review